Charni Laura, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5756 S Biscay St, Aurora, CO 80015 Phone: 720-886-3465 |
Taylor Anne Denton, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15701 E 1st Ave Ste 106, Aurora, CO 80011 Phone: 303-344-8060 |
Tracy L Klugger, ST Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 Fax: 309-672-4569 |
Miss Aimee Lynn Stang, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Box 030, Aurora, CO 80045 Phone: 720-777-1234 |
Brooke Goldman, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15701 E 1st Ave # 80011, Aurora, CO 80011 Phone: 303-344-8060 |
Megan Ann Campion, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3131 S Vaughn Way Ste 110, Aurora, CO 80014 Phone: 630-846-8436 |
Kelly Josephine Berrigan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15701 E 1st Ave, Aurora, CO 80011 Phone: 303-344-8060 |
Dana J. Boyd, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6525 S Wheatlands Pkwy, Aurora, CO 80016 Phone: 720-886-8824 |
Catherine Margaret O'meara, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 S Kalispell Way, Aurora, CO 80017 Phone: 303-696-0944 |
Shelly A Elfner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
Joely L Neptune, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4801 S Carson St, Aurora, CO 80015 Phone: 714-337-2008 |
Kendra Michele Martellaro, MA CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 900 Potomac St, Aurora, CO 80011 Phone: 303-695-2600 |
Ashley Grover Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-9112 |
Ella Wente Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6155 S Main St Ste 200, Aurora, CO 80016 Phone: 720-542-8737 |
Paige Wikman, M.S., SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13121 E 17th Ave, Aurora, CO 80045 Phone: 303-724-5266 |
Celia Wittrock Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4350 S Pitkin St, Aurora, CO 80015 Phone: 720-886-5840 |
Jessica Renee Villacres, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15701 E 1st Ave, Aurora, CO 80011 Phone: 303-344-8060 |
Amy Fullmer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14800 E Belleview Dr, Aurora, CO 80015 Phone: 303-400-2220 |
Sarita Scott, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15701 E 1st Ave Ste 106, Aurora, CO 80011 Phone: 303-344-8060 |
Laura Kay Smith, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15611 E Caspian Cir Apt 302, Aurora, CO 80013 Phone: 720-480-4977 |
News Archive
Selenium, Ltd., a biopharmaceutical company focused on unique solutions to meet antimicrobial coating and therapeutic needs, has been awarded a research grant from the National Institute on Deafness and Other Communication Disorders, one of the National Institutes of Health. With the $155,387 NIH grant the company will apply its proprietary antimicrobial technology to researching the inhibition of biofilms on tympanostomy tubes.
Doctors believe that communication with those under their care is important, but most studies of communication between physicians and older adults do not mention that hearing loss may affect this interaction. The findings come from a review published in the Journal of the American Geriatrics Society.
Ospemifene (tradename: Senshio) is approved for the treatment of moderate to severe symptomatic vulvovaginal atrophy (VVA) in post-menopausal women who are not candidates for local vaginal oestrogen therapy.
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.
› Verified 1 days ago